Bruce R Ito Selected Research

2- ((3,5- dimethyl- 4- (4'- hydroxy- 3'- isopropylbenzyl)phenoxy)methyl)- 4- (3- chlorophenyl)- 2- oxido(1,3,2)dioxaphosphonane

2/2009	Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.
9/2007	Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce R Ito Research Topics

Disease

1	Infarction (Infarctions) 12/2019
1	Inflammation (Inflammations) 12/2019
1	Heart Failure 12/2019
1	Insulin Resistance 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Obesity 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Non-alcoholic Fatty Liver Disease 02/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2009
1	Body Weight (Weight, Body) 09/2007
1	Ischemia 09/2003

Drug/Important Bio-Agent (IBA)

2	2- ((3,5- dimethyl- 4- (4'- hydroxy- 3'- isopropylbenzyl)phenoxy)methyl)- 4- (3- chlorophenyl)- 2- oxido(1,3,2)dioxaphosphonaneIBA 02/2009 - 09/2007
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 12/2019
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	Transaminases (Aminotransferases)IBA 02/2009
1	Nonesterified Fatty Acids (NEFA)IBA 02/2009
1	LDL CholesterolIBA 02/2009
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 02/2009
1	Thyroid HormonesIBA 02/2009
1	KB 141IBA 09/2007
1	Triglycerides (Triacylglycerol)IBA 09/2007
1	CholesterolIBA 09/2007
1	AutacoidsIBA 09/2003
1	Adenosine (Adenocard)FDA LinkGeneric 09/2003
1	CatecholaminesIBA 09/2003

Therapy/Procedure

1	Aftercare (After-Treatment) 02/2009